E Fund Management Co., Ltd. Immunity Bio, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
A detailed history of E Fund Management Co., Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 28,108 shares of IBRX stock, worth $71,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,108
Previous 30,331
7.33%
Holding current value
$71,113
Previous $91,000
18.68%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
273Shares Held
120MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$55.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.9 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$22.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.6 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.5 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.01B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...